FDA and CMS seek state partnerships on AI regulation and liability in healthcare

Federal officials are aiming to collaborate with states on regulating artificial intelligence in healthcare and on measures to protect doctors from liability related to AI use, according to STAT. The report says these efforts are part of a broader push to address legal and regulatory issues as AI becomes more common in clinical settings.

For healthcare and pharma executives, this signals a potential shift in compliance requirements and risk management. Leaders should monitor how these collaborations develop, as changes could affect both operational policies and legal exposure when deploying AI tools in care delivery.